|
Cipla appoints President & Global Chief – Integrated Product Development> |
|
Board of Cipla recommends final dividend> |
|
Cipla consolidated net profit declines 54.61% in the March 2026 quarter> |
|
Cipla Q4 profit declines 55% YoY> |
|
Cipla gains after USFDA nod for generic albuterol inhaler> |
|
Cipla Ltd spurts 4.25%, gains for third straight session> |
|
Cipla's manufacturing facility in Goa gets two observations in Form 483 from US FDA> |
|
Cipla's Goa unit completes USFDA inspection with two observations> |
|
Cipla consolidated net profit declines 56.97% in the December 2025 quarter> |
|
Cipla slides as Q3 PAT tanks 57% YoY to Rs 676 crore> |